The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another…

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (also known…

This is a randomised, double-blind, three-arm, parallel group, single-dose, Phase 1 comparative study of CKD-706, US-Dupixent, and EU-Dupixent in healthy…

Dr Liz O'Riordan says it is important women seek help from professionals not "Google and Chat GPT".

The Worcester woman says she wants endometriosis patients to be "met with a little extra comfort".

Over 60% of the women surveyed said being advised to have any of the vaccines by a healthcare professional was…

The non-hormonal daily pill could benefit 500,000 women for whom HRT is not suitable.